Adenylosuccinate synthetase-like 1-related distal myopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:482601OMIM:617030G71.0
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Adenylosuccinate synthetase-like 1-related distal myopathy, sometimes called ADSSL1 myopathy, is a rare inherited muscle disease caused by changes (mutations) in the ADSSL1 gene. This gene provides instructions for making an enzyme that plays an important role in energy production inside muscle cells. When this enzyme does not work properly, muscle cells — especially those in the hands, feet, and lower legs — gradually weaken and waste away over time. This type of muscle disease is called a 'distal myopathy' because it mainly affects the muscles farthest from the center of the body. People with this condition typically notice weakness and wasting in the muscles of the hands and lower legs, which can make everyday tasks like gripping objects, walking, or climbing stairs increasingly difficult. The disease usually begins in young adulthood, though the age of first symptoms can vary. Some people also experience muscle pain or cramping. The heart and breathing muscles are generally not affected in most reported cases, which is reassuring. There is currently no cure for ADSSL1 myopathy. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, occupational therapy, and assistive devices such as braces or orthotics can help people stay as independent as possible. Regular monitoring by a neuromuscular specialist is important to track how the disease is progressing and to adjust care as needed.

Also known as:

Key symptoms:

Weakness in the hands and fingersWeakness in the lower legs and feetMuscle wasting (shrinking) in the hands and lower legsDifficulty walking or foot drop (difficulty lifting the front of the foot)Trouble with fine hand movements like buttoning clothes or writingMuscle cramps or painReduced grip strengthDifficulty climbing stairsSlowly worsening symptoms over years

Clinical phenotype terms (37)— hover any for plain English
Generalized amyotrophyHP:0003700Quadriceps muscle weaknessHP:0003731Lower limb amyotrophyHP:0007210Distal upper limb muscle weaknessHP:0008959Quadriceps muscle atrophyHP:0009050Upper limb amyotrophyHP:0009129Fatigable weakness of chewing musclesHP:0030193
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Adenylosuccinate synthetase-like 1-related distal myopathy.

View clinical trials →

No actively recruiting trials found for Adenylosuccinate synthetase-like 1-related distal myopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Adenylosuccinate synthetase-like 1-related distal myopathy community →

Specialists

1 foundView all specialists →
PS
Perry B Shieh
LOS ANGELES, CA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Adenylosuccinate synthetase-like 1-related distal myopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Adenylosuccinate synthetase-like 1-related distal myopathyForum →

No community posts yet. Be the first to share your experience with Adenylosuccinate synthetase-like 1-related distal myopathy.

Start the conversation →

Latest news about Adenylosuccinate synthetase-like 1-related distal myopathy

No recent news articles for Adenylosuccinate synthetase-like 1-related distal myopathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic testing do you recommend to confirm my diagnosis, and should my family members be tested?,How quickly do you expect my symptoms to progress, and what signs should I watch for?,What physical or occupational therapy programs do you recommend for someone with my level of weakness?,Are there any clinical trials or research studies I might be eligible to join?,Should I see a cardiologist or pulmonologist to check if those muscles are affected?,What assistive devices or home modifications might help me stay safe and independent?,Are there any patient registries or support groups for people with ADSSL1 myopathy or distal myopathies?

Common questions about Adenylosuccinate synthetase-like 1-related distal myopathy

What is Adenylosuccinate synthetase-like 1-related distal myopathy?

Adenylosuccinate synthetase-like 1-related distal myopathy, sometimes called ADSSL1 myopathy, is a rare inherited muscle disease caused by changes (mutations) in the ADSSL1 gene. This gene provides instructions for making an enzyme that plays an important role in energy production inside muscle cells. When this enzyme does not work properly, muscle cells — especially those in the hands, feet, and lower legs — gradually weaken and waste away over time. This type of muscle disease is called a 'distal myopathy' because it mainly affects the muscles farthest from the center of the body. People wi

How is Adenylosuccinate synthetase-like 1-related distal myopathy inherited?

Adenylosuccinate synthetase-like 1-related distal myopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Adenylosuccinate synthetase-like 1-related distal myopathy typically begin?

Typical onset of Adenylosuccinate synthetase-like 1-related distal myopathy is adult. Age of onset can vary across affected individuals.

Which specialists treat Adenylosuccinate synthetase-like 1-related distal myopathy?

1 specialists and care centers treating Adenylosuccinate synthetase-like 1-related distal myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.